What is the current Poloxamer 338 market size?

The Poloxamer 338 market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Poloxamer 338 market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Poloxamer 338 market?

Increasing demand from pharmaceutical and cosmetic industries drives the market.

What are the challenges facing the Poloxamer 338 market?

Stringent regulations and high production costs are major challenges.

Which regions are the leaders in the Poloxamer 338 market?

North America and Europe are the leading regions.

Who are the top companies in the Poloxamer 338 market?

BASF and Dow Chemical are among the top companies.

What are the future opportunities in the Poloxamer 338 market?

Growing demand from emerging economies presents future opportunities.

How does technology impact the Poloxamer 338 market?

Advances in technology improve production efficiency and reduce costs.

What is the regulatory landscape for the Poloxamer 338 market?

Regulations vary by region, with FDA and EU guidelines governing the market.

What is the future outlook for the Poloxamer 338 market?

The market is expected to grow steadily, driven by increasing demand.

Poloxamer 338 Expansion Opportunities & Forecast Analysis 2033

Poloxamer 338 by Application (Cosmetic, Pharmaceuticals, Others), by Types (Purity 99%, Purity 99.9%, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Poloxamer 338 Market Size | CAGR 8.2 Forecast 2033

Poloxamer 338 Expansion Opportunities & Forecast Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Poloxamer 338 Market Overview

The Poloxamer 338 market refers to the global industry involved in the production and distribution of Poloxamer 338, a nonionic triblock copolymer used in various applications. The Poloxamer 338 market size is estimated to be around $145 million, with a growth outlook that is expected to drive the market forward. As we look ahead to the market forecast, it is clear that the industry is poised for significant expansion, with a compound annual growth rate (CAGR) of 5-7% expected during the forecast period. The industry expansion will be driven by key factors such as increasing demand from the pharmaceutical and personal care sectors, as well as advancements in technology and manufacturing processes. The scope of the market includes various applications, such as surfactants, emulsifiers, and solubilizers, and end-users, including pharmaceutical companies, personal care product manufacturers, and research institutions.

Loading chart…

The growth of the Poloxamer 338 market will be shaped by several key forces, including technology shifts, such as the development of new manufacturing processes and the use of more sustainable materials, regulations, such as changes in government policies and standards, and consumer behavior, such as increasing demand for natural and organic products. The largest region for the Poloxamer 338 market is currently North America, while the fastest-growing region is expected to be Asia-Pacific. The market will continue to evolve as new applications and end-users emerge, driving industry expansion and market forecast growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BASF; Croda International plc; CD Formulation; Comercial Química Massó
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Poloxamer 338 market is poised for significant growth, driven by increasing demand from various end-use industries. The market dynamics are shaped by a combination of factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Rising demand for Poloxamer 338 in the pharmaceutical industry, particularly in the formulation of oral and topical medications, is expected to drive market growth. The unique properties of Poloxamer 338, such as its ability to solubilize and stabilize active pharmaceutical ingredients, make it an essential excipient in various drug delivery systems.

Growing adoption of Poloxamer 338 in the cosmetic and personal care industry, driven by its moisturizing and emulsifying properties, is also contributing to the market's expansion. The increasing use of Poloxamer 338 in skincare and haircare products is anticipated to further boost the market size and growth forecast.

Restraints2 items

Stringent regulatory requirements and quality standards for Poloxamer 338 may limit the market growth, as manufacturers must comply with Good Manufacturing Practice (GMP) guidelines and ensure the product meets the required purity and consistency standards.

Fluctuations in the prices of raw materials, such as polyethylene oxide and polypropylene oxide, can impact the production costs of Poloxamer 338, affecting the market's overall profitability and Poloxamer 338 market size.

Opportunities2 items

The increasing demand for Poloxamer 338 in emerging economies, such as Asia Pacific and Latin America, presents opportunities for market players to expand their geographical presence and increase their market share. The growing middle-class population and rising healthcare expenditure in these regions are expected to drive the demand for Poloxamer 338.

The development of new applications for Poloxamer 338, such as in the food and beverage industry, can further diversify the market and provide opportunities for growth. The use of Poloxamer 338 as a food additive or ingredient can help manufacturers create innovative products with improved texture and stability.

Challenges2 items

The Poloxamer 338 market is characterized by intense competition, with several established players competing for market share. The high level of competition can lead to pricing pressure, making it challenging for manufacturers to maintain profit margins and achieve a favorable growth forecast.

The impact of macroeconomic factors, such as economic downturns and trade wars, can affect the Poloxamer 338 market, as changes in global trade policies and economic conditions can influence the demand for Poloxamer 338 and disrupt the supply chain.

Market Segmentation

Loading chart…

The Poloxamer 338 market can be segmented based on Application, which includes pharmaceuticals, cosmetics, and industrial applications. The pharmaceuticals segment holds a significant share of the Poloxamer 338 market, driven by the increasing demand for solubilizing agents and surfactants in drug delivery systems. The cosmetics segment is also expected to grow, driven by the use of Poloxamer 338 in personal care products such as skincare creams and lotions.

In terms of Types, the Poloxamer 338 market can be segmented into [object Object] and [object Object] subtypes. These subtypes are characterized by their unique molecular weight and hydrophile-lipophile balance, which affect their performance in various applications. Understanding the Poloxamer 338 segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

Poloxamer 338 Segmentation Breakdown8 items

Application

Cosmetic

Pharmaceuticals

Others

Types

Purity 99%

Purity 99.9%

Others

Regional Insights

Loading chart…

The Poloxamer 338 market growth is expected to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market. This region is also anticipated to be the fastest-growing, driven by key factors such as increasing adoption of Poloxamer 338 in the pharmaceutical and cosmetic industries, government policies supporting the growth of these industries, and significant investments in research and development.

In North America, key drivers include a mature ecosystem, high demographics of the aging population, and a well-established infrastructure for the production and distribution of Poloxamer 338, contributing to a regional share of around 25%. Europe is expected to account for approximately 20% of the market, driven by factors such as stringent regulations promoting the use of high-quality excipients like Poloxamer 338, a strong pharmaceutical industry, and a growing cosmetics market.

Latin America and Middle East & Africa are anticipated to account for around 10% and 5% of the global Poloxamer 338 market, respectively. Key drivers in these regions include growing demand for pharmaceuticals and cosmetics, increasing foreign investments, and improving infrastructure. The regional forecast indicates that these regions will experience steady growth, driven by expanding healthcare and personal care industries.

Competitive Landscape

The Poloxamer 338 market is moderately consolidated, with a mix of global players and local companies competing on various levers such as pricing, distribution, and product innovation. The Poloxamer 338 competitive landscape is characterized by high competition, with key players focusing on certifications, regulatory approvals, and strategic partnerships to differentiate themselves. Global players have a significant presence, but local companies are also gaining traction by offering customized solutions and leveraging their regional strengths.

Companies in the Poloxamer 338 market are adopting various strategies to stay competitive, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies are focusing on technology, service models, and channel strength, as well as offering customized solutions and cost advantages. The following companies are implementing these strategies:

BASF: regional expansion

Croda International plc: innovation pipeline

CD Formulation: local manufacturing

Comercial Química Massó: premium pricing

BASF: vertical integration

Croda International plc: OEM tie-ups

Key Poloxamer 338 Companies4 items

BASF

Croda International plc

CD Formulation

Comercial Química Massó

Market Ecosystem

The Poloxamer 338 ecosystem encompasses a complex network of participants, spanning upstream raw material suppliers to downstream end users. This ecosystem can be broadly categorized into three main segments: upstream technology providers and suppliers, midstream integrators and channels, and downstream end users. Value is created and captured at each stage, from the development of Poloxamer 338 to its integration into final products and eventual use by end users.

Raw material suppliers — provide chemical components

Technology providers — develop Poloxamer 338 manufacturing processes

OEMs / manufacturers — produce Poloxamer 338-based products

System integrators / EPCs — formulate and blend Poloxamer 338

Distributors / channel partners — deliver Poloxamer 338 to manufacturers

Regulators/standards bodies — establish Poloxamer 338 safety and quality standards

End users / buyers — purchase and use Poloxamer 338-based products

In the Poloxamer 338 ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through safety and quality standards. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals. Switching costs and partnerships can also impact the ecosystem, particularly in terms of interoperability requirements. As part of a comprehensive value chain analysis, understanding these dynamics is crucial for navigating the Poloxamer 338 ecosystem, which may differ by region due to varying regulatory environments and market demands.

Recent Industry Insights

The Poloxamer 338 industry trends have witnessed significant developments over the last 12-18 months, driven by strategic partnerships, mergers, and acquisitions. Notably, key players have been focusing on expanding their product portfolios through innovative launches and technological advancements. Recent funding rounds and expansions have also been instrumental in shaping the industry landscape. Furthermore, regulatory changes and shifts in consumer preferences have prompted companies to adapt and innovate, ultimately driving growth in the Poloxamer 338 market.

In terms of specifics, the industry has seen a surge in sustainable and eco-friendly product developments, catering to the increasing demand for environmentally responsible solutions. As the Poloxamer 338 industry continues to evolve, it is likely that we will see more emphasis on research and development, leading to the creation of novel applications and uses for Poloxamer 338. Overall, the future of the Poloxamer 338 industry looks promising, with emerging trends and technologies poised to drive long-term growth and success.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Poloxamer 338 market outlook. The market attractiveness is moderate, driven by growing demand from the pharmaceutical and cosmetic industries. Competitive intensity is high, with several key players competing for market share. The long-term outlook is promising, with opportunities for innovation and expansion into new applications.

The innovation landscape is characterized by ongoing research and development in sustainable and efficient production methods. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and fluctuations in raw material prices. Overall, the Poloxamer 338 market is poised for growth, driven by increasing demand and innovation.

11 items

1. Executive Summary

2. Poloxamer 338 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Poloxamer 338 Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Poloxamer 338 Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cosmetic

6.1.2. Pharmaceuticals

6.1.3. Others

6.2. Global Poloxamer 338 Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Purity 99%

6.2.2. Purity 99.9%

6.2.3. Others

6.3. Global Poloxamer 338 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Poloxamer 338 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Poloxamer 338 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Poloxamer 338 Market Competition by Key Manufacturers

8.1. Global Poloxamer 338 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Poloxamer 338: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BASF

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Croda International plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. CD Formulation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Comercial Química Massó

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Poloxamer 338 Market

Figure 4: Global Poloxamer 338 Market: Drivers

Figure 5: Global Poloxamer 338 Market: Challenges

Figure 6: Global Poloxamer 338 Market: Trends

Figure 7: Global Poloxamer 338 Market: Opportunity

Figure 8: Global Poloxamer 338 Market: Restraint

Figure 9: Global Poloxamer 338 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Poloxamer 338 Market Value (USD Million) By Region

Figure 15: Global Poloxamer 338 Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Poloxamer 338 Market Value (USD Million) By Region

Figure 23: Global Poloxamer 338 Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

61 items

Table 1: Market Segmentation Analysis

Table 2: Global Poloxamer 338 Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Poloxamer 338 Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Poloxamer 338 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Poloxamer 338 Market Value (USD Million) By Region

Table 10: Global Poloxamer 338 Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Poloxamer 338 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Poloxamer 338 Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Poloxamer 338 Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BASF Basic Information And Sales Area

Table 31: BASF. Products Portfolio

Table 32: Croda International plc Basic Information And Sales Area

Table 33: Croda International plc. Products Portfolio

Table 34: CD Formulation Basic Information And Sales Area

Table 35: CD Formulation. Products Portfolio

Table 36: Comercial Química Massó Basic Information And Sales Area

Table 37: Comercial Química Massó. Products Portfolio

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Market Value (USD Million) (2025-2032) By Types

Table 41: Global Market Share (%) By Types (2032)

Table 42: Global Poloxamer 338 Market Value (USD Million) By Region

Table 43: Global Poloxamer 338 Market Share (%) By Region (2025-2032)

Table 44: North America Market Value (USD Million) (2025-2032) By Country

Table 45: North America Market Value (USD Million) (2025-2032) By Application

Table 46: North America Market Value (USD Million) (2025-2032) By Types

Table 47: Europe Market Value (USD Million) (2025-2032) By Country

Table 48: Europe Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Types

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 51: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 53: South America Market Value (USD Million) (2025-2032) By Country

Table 54: South America Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Types

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 57: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 59: Research Programs/Design For This Report

Table 60: Key Data Information From Secondary Sources

Table 61: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Poloxamer 338 Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BASF; Croda International plc; CD Formulation; Comercial Química Massó
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options